Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 EUR | -0.96% | -9.65% | -42.05% |
May. 13 | AB Science: European patent granted for masitinib | CF |
May. 03 | AB Science: upbeat after legal success | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.05% | 118M | |
+14.82% | 78.22B | |
+8.25% | 8.84B | |
-12.05% | 5.07B | |
+53.66% | 4.82B | |
+11.63% | 4.2B | |
-23.67% | 2.28B | |
+9.96% | 2.28B | |
-32.35% | 2.12B | |
+21.04% | 2.2B |
- Stock Market
- Equities
- AB Stock
- News AB Science
- AB Science : Masitinib Treatment Against Pancreatic Cancer Boosts Survival Rates